ZA8993B - Medical treatment - Google Patents

Medical treatment

Info

Publication number
ZA8993B
ZA8993B ZA8993A ZA8993A ZA8993B ZA 8993 B ZA8993 B ZA 8993B ZA 8993 A ZA8993 A ZA 8993A ZA 8993 A ZA8993 A ZA 8993A ZA 8993 B ZA8993 B ZA 8993B
Authority
ZA
South Africa
Prior art keywords
medical treatment
treatment
retrovivus
deoxythymidine
azido
Prior art date
Application number
ZA8993A
Other languages
English (en)
Inventor
Charles Anthony Hart
Anthony Hart Charles
Kevin Mccarthy
Mccarthy Kevin
Samuel John Leinster
John Leinster Samuel
Christopher Douglas Green
Douglas Green Christopher
Ayad Mohamed Khala Al-Sumidaie
Mohamed Khalaf Al-Sumidai Ayad
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Publication of ZA8993B publication Critical patent/ZA8993B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
ZA8993A 1988-01-07 1989-01-05 Medical treatment ZA8993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800276A GB8800276D0 (en) 1988-01-07 1988-01-07 Medical treatment

Publications (1)

Publication Number Publication Date
ZA8993B true ZA8993B (en) 1989-10-25

Family

ID=10629601

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA8993A ZA8993B (en) 1988-01-07 1989-01-05 Medical treatment

Country Status (15)

Country Link
US (1) US5223490A (da)
EP (1) EP0327200B1 (da)
JP (1) JP2761420B2 (da)
KR (1) KR900700110A (da)
CN (1) CN1034134A (da)
AT (1) ATE83378T1 (da)
AU (1) AU626284B2 (da)
CA (1) CA1331138C (da)
DE (1) DE68903840T2 (da)
DK (1) DK173766B1 (da)
GB (1) GB8800276D0 (da)
IE (1) IE63788B1 (da)
MY (1) MY104462A (da)
WO (1) WO1989006132A1 (da)
ZA (1) ZA8993B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823353D0 (en) * 1988-10-05 1988-11-09 Wellcome Found Therapeutic nucleosides
FR2649982B1 (fr) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med Membrane biologique artificielle
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
US5576177A (en) * 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
EP1174141A3 (en) * 1996-01-23 2003-04-23 ICN Pharmaceuticals, Inc. Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes
PE20000066A1 (es) * 1997-12-22 2000-02-09 Schering Corp Formas de dosificacion solida de ribavirina administrables oralmente y proceso de fabricacion
US7351542B2 (en) * 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
WO2005090316A1 (en) * 2004-03-12 2005-09-29 Wyeth HYDANTOINS HAVING RNase MODULATORY ACTIVITY
US20050203176A1 (en) * 2004-03-12 2005-09-15 Wyeth Carbamates as HIV anti-viral agents
WO2005090320A2 (en) * 2004-03-12 2005-09-29 Wyeth Triazole derivatives and method of using the same to treat hiv infections
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2007123579A2 (en) * 2005-12-28 2007-11-01 Translational Therapeutics Translational dysfunction based therapeutics
US7725227B2 (en) * 2006-12-15 2010-05-25 Gm Global Technology Operations, Inc. Method, system, and apparatus for providing enhanced steering pull compensation
TW202228724A (zh) * 2020-09-23 2022-08-01 美商昂克萊亞製藥公司 以反轉錄酶抑制劑治療癌症之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE73219B1 (en) * 1985-03-16 1997-05-07 Wellcome Found Therapeutic nucleosides
GB8506869D0 (en) * 1985-03-16 1985-04-17 Wellcome Found Antiviral compound
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
DD262802A5 (de) * 1985-09-17 1988-12-14 The Wellcome Foundation Limited,Gb Verfahren zur herstellung einer pharmazeutischen formulierung

Also Published As

Publication number Publication date
JPH03503049A (ja) 1991-07-11
EP0327200A1 (en) 1989-08-09
DK173766B1 (da) 2001-09-24
DK162190D0 (da) 1990-07-05
ATE83378T1 (de) 1993-01-15
CN1034134A (zh) 1989-07-26
AU2949889A (en) 1989-08-01
JP2761420B2 (ja) 1998-06-04
GB8800276D0 (en) 1988-02-10
WO1989006132A1 (en) 1989-07-13
CA1331138C (en) 1994-08-02
DE68903840T2 (de) 1993-06-17
IE890036L (en) 1989-07-07
DK162190A (da) 1990-07-05
KR900700110A (ko) 1990-08-11
AU626284B2 (en) 1992-07-30
IE63788B1 (en) 1995-06-14
DE68903840D1 (de) 1993-01-28
EP0327200B1 (en) 1992-12-16
US5223490A (en) 1993-06-29
MY104462A (en) 1994-04-30

Similar Documents

Publication Publication Date Title
GB8800276D0 (en) Medical treatment
AU1808488A (en) Compounds for the treatment of alzheimer's disease
GB8807775D0 (en) Coagulation treatment of fluids
HU9302384D0 (en) 2,4-diamino-quinazoline derivatives and medical preparatives containing them
DE3475266D1 (en) Table with adjustable inclination for body stretching
ZA871860B (en) Transglutaminase inhibitors
IN173057B (da)
DK168189A (da) Topisk praeparat til behandling af otopati
IL87452A (en) Calcium citrate malate and calcium supplements containing it
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
IE880334L (en) Use of human blood coagulation factor XIII for the treatment¹of ulcerative colitis
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0270782A3 (en) Therapeutic agents for the prophylaxis of tumour metastasis
GR3005231T3 (da)
DE69009989D1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
EP0407788A3 (en) Use of retinoids for the treatment and prophylaxis of immune related diseases
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
ZA844114B (en) 6(or 5)-hydroxybenzothiazole-2-sulfonamide-o-sulfate salts for the topical treatment of elevated intraocular pressure
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
PHUM6382Z (en) Composition for the treatment of pimples